Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer immunoglobulin-like receptors (KIRs) are expressed on natural killer cells and some T-cell subsets and produce either activation or inhibitory signals upon binding with the appropriate human leucocyte antigen (HLA) ligand on target cells. Recent genetic association studies have implicated KIR...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Jones, D, Edgar, R, Ahmad, T, Cummings, JR, Jewell, D, Trowsdale, J, Young, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2006

Παρόμοια τεκμήρια

Association of Killer Cell Immunoglobulin-like Receptor (KIR) Genes and their HLA Ligands with Susceptibility to Takayasu Arteritis in the Iranian Population
ανά: Fereshteh Beigmohammadi, κ.ά.
Έκδοση: (2023-02-01)

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
ανά: Suliman Y. Al Omar, κ.ά.
Έκδοση: (2016-03-01)

Ulcerative colitis and HLA phenotype.
ανά: Cottone, M, κ.ά.
Έκδοση: (1985)

Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
ανά: Gibson, P, κ.ά.
Έκδοση: (1985)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
ανά: Daniela Maira Cardozo, κ.ά.
Έκδοση: (2023-07-01)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
ανά: Antonino Tuttolomondo, κ.ά.
Έκδοση: (2019-04-01)

Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
ανά: Hiromi Saito, κ.ά.
Έκδοση: (2018-01-01)

The association of the killer cell immunoglobulin-like receptor (KIR) genotype distribution and HLA-C ligands in colorectal cancer in the eastern region of Saudi Arabia
ανά: Sarah Alqadheeb, κ.ά.
Έκδοση: (2024-07-01)

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
ανά: Viktoria Varbanova, κ.ά.
Έκδοση: (2019-11-01)

Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population
ανά: Suliman Alomar, κ.ά.
Έκδοση: (2023-01-01)

Oral methotrexate in ulcerative colitis.
ανά: Cummings, JR, κ.ά.
Έκδοση: (2005)

Natural Killer Cells and Cancer--Regulation by the Killer Cell Ig-like Receptors (KIR)
ανά: Amanda K. PURDY, κ.ά.
Έκδοση: (2010-07-01)

Ulcerative colitis and Crohn's disease--susceptibility genes and clinical patterns.
ανά: Jewell, D
Έκδοση: (1998)

KIR-HLA gene diversities and susceptibility to lung cancer
ανά: Marjan Hematian Larki, κ.ά.
Έκδοση: (2022-10-01)

Ulcerative colitis.
ανά: Jewell, D
Έκδοση: (1975)

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
ανά: Aura Burian, κ.ά.
Έκδοση: (2016-01-01)

Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.
ανά: Barr, G, κ.ά.
Έκδοση: (1987)

Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation
ανά: Davood Jafari, κ.ά.
Έκδοση: (2017-06-01)

Killer Cell Ig-like Receptors (KIR)-Binding Assay for Tumor Cells
ανά: Loredana Cifaldi, κ.ά.
Έκδοση: (2016-09-01)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
ανά: Jing-Jie Guo, κ.ά.
Έκδοση: (2022-11-01)

Aetiopathogenesis of ulcerative colitis.
ανά: Jewell, D
Έκδοση: (1987)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
ανά: Chrissy H Roberts, κ.ά.
Έκδοση: (2014-03-01)

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity
ανά: Stephen Tukwasibwe, κ.ά.
Έκδοση: (2021-02-01)

Association of genetic variants of KIR2DL4 and its ligand HLA-G gene with HCV susceptibility and chronicity
ανά: Ze-pei FENG, κ.ά.
Έκδοση: (2023-03-01)

HLA TYPING OF ULCERATIVE COLITIS IN IRAN
ανά: Froutan, κ.ά.
Έκδοση: (1996-06-01)

HLA TYPING OF ULCERATIVE COLITIS IN IRAN
ανά: Froutan, κ.ά.
Έκδοση: (1996-06-01)

Azathioprine in ulcerative colitis.
ανά: Jewell, D, κ.ά.
Έκδοση: (1972)

Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop
ανά: Misra, MK, κ.ά.
Έκδοση: (2018)

Infliximab for ulcerative colitis.
ανά: Simmons, J, κ.ά.
Έκδοση: (2002)

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
ανά: Ying Qi, κ.ά.
Έκδοση: (2006-08-01)

Proceedings: Etiology of ulcerative colitis.
ανά: Jewell, D
Έκδοση: (1973)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
ανά: Hatano, H, κ.ά.
Έκδοση: (2013)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
ανά: Rehan Mujeeb Faridi, κ.ά.
Έκδοση: (2016-01-01)

Ulcerative colitis and sarcoidosis.
ανά: Barr, G, κ.ά.
Έκδοση: (1986)

Reaginic hypersensitivity in ulcerative colitis.
ανά: Jewell, D, κ.ά.
Έκδοση: (1972)

Disodium azodisalicylate in ulcerative colitis.
ανά: Jewell, D, κ.ά.
Έκδοση: (1981)

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
ανά: Vlad Andrei Cianga, κ.ά.
Έκδοση: (2023-03-01)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
ανά: Wong-Baeza, I, κ.ά.
Έκδοση: (2011)

Genetics of ulcerative colitis.
ανά: Satsangi, J, κ.ά.
Έκδοση: (1996)

Study on relationship between platelet transfusion efficacy and KIR-HLA receptor-ligand compatibility
ανά: Yu HAN, κ.ά.
Έκδοση: (2023-07-01)